vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and LXP Industrial Trust (LXP). Click either name above to swap in a different company.

LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $73.1M, roughly 1.2× Evolus, Inc.). LXP Industrial Trust runs the higher net margin — 33.2% vs -14.6%, a 47.8% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -14.0%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs 0.3%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.

EOLS vs LXP — Head-to-Head

Bigger by revenue
LXP
LXP
1.2× larger
LXP
$86.7M
$73.1M
EOLS
Growing faster (revenue YoY)
EOLS
EOLS
+20.7% gap
EOLS
6.7%
-14.0%
LXP
Higher net margin
LXP
LXP
47.8% more per $
LXP
33.2%
-14.6%
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
4.6%
0.3%
LXP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EOLS
EOLS
LXP
LXP
Revenue
$73.1M
$86.7M
Net Profit
$-10.7M
$28.8M
Gross Margin
66.9%
81.5%
Operating Margin
23.8%
34.6%
Net Margin
-14.6%
33.2%
Revenue YoY
6.7%
-14.0%
Net Profit YoY
EPS (diluted)
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
LXP
LXP
Q1 26
$73.1M
Q4 25
$90.3M
$86.7M
Q3 25
$69.0M
$86.9M
Q2 25
$69.4M
$87.7M
Q1 25
$68.5M
$88.9M
Q4 24
$78.9M
$100.9M
Q3 24
$61.1M
$85.6M
Q2 24
$66.9M
$85.8M
Net Profit
EOLS
EOLS
LXP
LXP
Q1 26
$-10.7M
Q4 25
$130.0K
$28.8M
Q3 25
$-15.7M
$36.3M
Q2 25
$-17.1M
$29.1M
Q1 25
$-18.9M
$19.0M
Q4 24
$-6.8M
Q3 24
$-19.2M
$6.3M
Q2 24
$-11.3M
$5.4M
Gross Margin
EOLS
EOLS
LXP
LXP
Q1 26
66.9%
Q4 25
65.7%
81.5%
Q3 25
66.5%
82.3%
Q2 25
65.3%
81.9%
Q1 25
68.1%
80.7%
Q4 24
66.7%
85.3%
Q3 24
68.9%
82.5%
Q2 24
70.3%
82.0%
Operating Margin
EOLS
EOLS
LXP
LXP
Q1 26
23.8%
Q4 25
4.7%
34.6%
Q3 25
-16.7%
50.4%
Q2 25
-14.7%
33.7%
Q1 25
-22.1%
21.8%
Q4 24
-2.9%
Q3 24
-25.3%
7.9%
Q2 24
-11.5%
6.9%
Net Margin
EOLS
EOLS
LXP
LXP
Q1 26
-14.6%
Q4 25
0.1%
33.2%
Q3 25
-22.8%
41.7%
Q2 25
-24.7%
33.2%
Q1 25
-27.6%
21.4%
Q4 24
-8.6%
Q3 24
-31.4%
7.4%
Q2 24
-17.0%
6.3%
EPS (diluted)
EOLS
EOLS
LXP
LXP
Q1 26
$-0.16
Q4 25
$0.01
Q3 25
$-0.24
$0.12
Q2 25
$-0.27
$0.09
Q1 25
$-0.30
$0.06
Q4 24
$-0.11
Q3 24
$-0.30
$0.02
Q2 24
$-0.18
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
LXP
LXP
Cash + ST InvestmentsLiquidity on hand
$49.8M
$170.4M
Total DebtLower is stronger
$156.4M
$1.4B
Stockholders' EquityBook value
$2.0B
Total Assets
$220.6M
$3.5B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
LXP
LXP
Q1 26
$49.8M
Q4 25
$53.8M
$170.4M
Q3 25
$43.5M
$229.7M
Q2 25
$61.7M
$71.0M
Q1 25
$67.9M
$70.9M
Q4 24
$87.0M
$101.8M
Q3 24
$85.0M
$55.0M
Q2 24
$93.7M
$48.7M
Total Debt
EOLS
EOLS
LXP
LXP
Q1 26
$156.4M
Q4 25
$146.1M
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$121.8M
$1.5B
Q4 24
$121.5M
$1.6B
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
$-23.1M
$2.0B
Q3 25
$-28.8M
$2.1B
Q2 25
$-18.7M
$2.1B
Q1 25
$-6.6M
$2.1B
Q4 24
$5.5M
$2.1B
Q3 24
$5.9M
$2.1B
Q2 24
$19.3M
$2.1B
Total Assets
EOLS
EOLS
LXP
LXP
Q1 26
$220.6M
Q4 25
$225.9M
$3.5B
Q3 25
$219.0M
$3.7B
Q2 25
$228.8M
$3.7B
Q1 25
$213.4M
$3.8B
Q4 24
$232.6M
$3.8B
Q3 24
$229.6M
$3.9B
Q2 24
$233.8M
$3.9B
Debt / Equity
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
0.66×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.73×
Q4 24
22.00×
0.75×
Q3 24
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
LXP
LXP
Operating Cash FlowLast quarter
$188.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
6.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
$12.8M
$188.7M
Q3 25
$-14.7M
$63.5M
Q2 25
$-24.8M
$44.3M
Q1 25
$-15.6M
$39.0M
Q4 24
$4.8M
$211.2M
Q3 24
$-5.7M
$64.6M
Q2 24
$-6.5M
$38.5M
Free Cash Flow
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
FCF Margin
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Capex Intensity
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Cash Conversion
EOLS
EOLS
LXP
LXP
Q1 26
Q4 25
98.67×
6.56×
Q3 25
1.75×
Q2 25
1.52×
Q1 25
2.05×
Q4 24
Q3 24
10.18×
Q2 24
7.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

LXP
LXP

Segment breakdown not available.

Related Comparisons